Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hematology

Can Female Hemophilia Carriers Bleed and Pass On the Gene?

At a Glance

If the biological father does not have hemophilia, a female carrier has a 50% chance in each pregnancy of passing an altered F8 or F9 gene. Her own factor levels can also be low, causing bleeding that needs planning for procedures, pregnancy, delivery, and postpartum care.

As a female carrier of hemophilia (meaning you have an altered F8 or F9 gene), your chances of passing the condition to your children depend on genetics. Assuming the biological father does not have hemophilia, each pregnancy carries an independent 50% chance that you will pass on the altered gene [1]:

  • Sons have a 50% chance of inheriting the gene and being born with hemophilia.
  • Daughters have a 50% chance of inheriting the gene. If she does, she could also have low factor levels and experience bleeding symptoms just like you.

Beyond passing on the gene, being a carrier means you yourself may experience bleeding problems. Many female carriers have lower-than-normal clotting factor levels and can experience symptoms like heavy menstrual periods, frequent nosebleeds, or prolonged bleeding after childbirth and surgeries [2] [3].

Understanding Your Own Bleeding Risk

Historically, women who carry the hemophilia gene were thought to just pass the condition on without having symptoms themselves. We now know this is not true. Because of a process called X-chromosome inactivation (where one X chromosome is randomly turned off in each cell), female carriers can have a wide range of clotting factor levels [2] [4].

Current medical guidelines classify carriers based on their actual factor levels (Factor VIII for hemophilia A, or Factor IX for hemophilia B) and bleeding symptoms:

  • Hemophilia in Females: If your clotting factor level is below 40% of normal (0.40 IU/mL), you have hemophilia. Depending on your exact level, this is classified as mild (5% to just under 40%), moderate (1% to 5%), or severe (less than 1%) [2] [5].
  • Symptomatic Carriers: Even if your factor levels are 40% or higher, you are considered a “symptomatic carrier” if you experience abnormal bleeding [2] [5]. Studies show that some female carriers have bleeding issues even when their factor levels appear normal [6] [7].

Common Symptoms

If you are a symptomatic carrier or have hemophilia, you might notice:

  • Heavy Menstrual Bleeding: Periods that are abnormally heavy or last longer than usual [3] [8].
  • Frequent Epistaxis: Nosebleeds that happen often or are hard to stop, as well as easy gum bleeding [3] [9].
  • Surgical and Dental Bleeding: Prolonged bleeding after having a tooth pulled or undergoing surgery [3] [9].

When to Seek Urgent Care

Seek emergency care or contact your hemophilia treatment center immediately if you experience:

  • Bleeding from a cut or injury that will not stop with firm pressure.
  • Any significant head injury.
  • Severe joint or muscle pain, or unexpected severe abdominal pain.
  • Signs of heavy blood loss, such as rapidly soaking through pads, passing large blood clots, dizziness, severe weakness, or fainting.

Treatments and Procedures

Do not wait until you are bleeding to ask for help. Before any dental work or surgery, contact your hemophilia treatment center to create a procedure-specific plan. Treatments for bleeding or surgery preparation include:

  • Hormonal therapies or antifibrinolytics (medicines like tranexamic acid that prevent blood clots from breaking down) [8] [10].
  • Factor concentrates to temporarily replace the missing clotting factor [10].
  • Desmopressin (DDAVP), which is only used for some patients with hemophilia A after testing confirms they respond to it. It is not a treatment for hemophilia B [10] [11].

Managing Pregnancy and Delivery

If you are planning to become pregnant, work with both a hematologist and an obstetrician.

  • Factor Testing: Your factor levels should be checked before pregnancy and again in the third trimester. This is because Factor VIII often rises naturally during pregnancy, but Factor IX usually does not [12] [10].
  • Epidurals and Delivery Planning: To safely receive an epidural (neuraxial anesthesia), your factor levels generally must be confirmed to be above 50% (0.50 IU/mL) before the catheter is placed and maintained at that level when it is removed [13] [10].
  • Protecting the Baby: Knowing the baby’s risk helps guide delivery choices. Your doctors may avoid using forceps, vacuum extraction, or fetal scalp electrodes if there is a chance the infant could have hemophilia. However, a cesarean delivery (C-section) is not automatically required and depends on normal obstetric reasons [13] [10].
  • Postpartum Care: Factor levels can drop rapidly after delivery, putting you at risk for delayed postpartum hemorrhage (heavy bleeding days or weeks after childbirth). Your medical team should provide a clear plan for monitoring and treating this risk [13] [12].

Common questions in this guide

How likely is a child of a female hemophilia carrier to inherit the altered gene?
If the biological father does not have hemophilia, each pregnancy has a 50% chance that the mother will pass on her altered F8 or F9 gene. A son who inherits it will have hemophilia; a daughter who inherits it will usually be a carrier but may also have low factor levels and bleeding symptoms.
Can a female hemophilia carrier have bleeding symptoms herself?
Yes. Factor VIII or IX levels can vary because one X chromosome is randomly turned off in each cell. Carriers may have heavy menstrual bleeding, frequent nosebleeds, gum bleeding, or prolonged bleeding after surgery, dental work, or childbirth, even when their measured factor levels are in the usual range.
What factor level means a female carrier has hemophilia?
A Factor VIII or IX level below 40% of normal is classified as hemophilia in a female. Mild disease is 5% to just under 40%, moderate is 1% to 5%, and severe is less than 1%. A person with levels of 40% or higher who has abnormal bleeding may be classified as a symptomatic carrier.
What should I do before pregnancy, delivery, surgery, or an epidural?
Coordinate care between a hematologist, obstetrician, and hemophilia treatment center, and have Factor VIII or IX levels checked before pregnancy and again in the third trimester. For an epidural, levels generally need to be above 50% before the catheter is placed and when it is removed. A postpartum plan is important because factor levels can fall quickly after delivery and delayed heavy bleeding can occur.
What treatments can help prevent or control bleeding in a female carrier?
Depending on the factor level and situation, clinicians may use hormonal treatment, tranexamic acid or another antifibrinolytic, factor concentrates, or desmopressin. Desmopressin is used only for some people with hemophilia A after testing shows they respond to it; it is not a treatment for hemophilia B.
When is bleeding in a female hemophilia carrier an emergency?
Seek emergency care or contact your hemophilia treatment center immediately if bleeding will not stop with firm pressure, after any significant head injury, or with severe joint, muscle, or abdominal pain. Rapidly soaking pads, passing large clots, dizziness, severe weakness, or fainting can signal heavy blood loss and also require urgent care.

Get notified when new evidence is published on Hemophilia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    The effect of carriers' reproductive choices and pregnancy history on sporadic severe haemophilia: A 20-year retrospective study through a regional registry.

    Riccardi F, Coppola A, Rivolta GF, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(2)):308-315 doi:10.1111/hae.14490.

    PMID: 35060226
  2. 2

    A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.

    van Galen KPM, d'Oiron R, James P, et al.

    Journal of thrombosis and haemostasis : JTH 2021; (19(8)):1883-1887 doi:10.1111/jth.15397.

    PMID: 34327828
  3. 3

    Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal.

    Seck M, Faye BF, Sall A, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2017; (28(8)):642-645 doi:10.1097/MBC.0000000000000653.

    PMID: 28731872
  4. 4

    A Rare Case of Mild Hemophilia A in a Female with Mosaic Monosomy X and a De Novo F8 Variant.

    Pshenichnikova O, Salomashkina V, Yastrubinetskaya O, et al.

    International journal of molecular sciences 2025; (26(24)) doi:10.3390/ijms262411899.

    PMID: 41465324
  5. 5

    HOW I TREAT BLEEDING IN WOMEN AND GIRLS WITH HEMOPHILIA/ HEMOPHILIA CARRIERS.

    Lavin M, Abdul-Kadir R, Sidonio RF

    Blood 2026; doi:10.1182/blood.2026033366.

    PMID: 42574322
  6. 6

    Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.

    James PD, Mahlangu J, Bidlingmaier C, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2016; (22(6)):912-918 doi:10.1111/hae.13089.

    PMID: 27868369
  7. 7

    Regulation and importance of factor VIII levels in hemophilia A carriers.

    Cygan PH, Kouides PA

    Current opinion in hematology 2021; (28(5)):315-322 doi:10.1097/MOH.0000000000000667.

    PMID: 34397591
  8. 8

    Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders.

    Connell NT, Davies J, Abdul-Kadir R, Kaplan Z

    Haemophilia : the official journal of the World Federation of Hemophilia 2026; doi:10.1111/hae.70267.

    PMID: 41988968
  9. 9

    Hemophilia carrier's awareness, diagnosis, and management in emerging countries: a cross-sectional study in Côte d'Ivoire (Ivory Coast).

    Lambert C, Meité ND, Sanogo I, et al.

    Orphanet journal of rare diseases 2019; (14(1)):26 doi:10.1186/s13023-019-1005-9.

    PMID: 30709356
  10. 10

    Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.

    Pacheco LD, Saade GR, James AH

    Obstetrics and gynecology 2023; (141(3)):493-504 doi:10.1097/AOG.0000000000005083.

    PMID: 36800851
  11. 11

    Women and girls with haemophilia: Lessons learned.

    d'Oiron R, O'Brien S, James AH

    Haemophilia : the official journal of the World Federation of Hemophilia 2021; (27 Suppl 3()):75-81 doi:10.1111/hae.14094.

    PMID: 32985086
  12. 12

    Pregnancy management for patients with bleeding disorders.

    Patel N, Bannow BS

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):496-502 doi:10.1182/hematology.2025000742.

    PMID: 41348000
  13. 13

    Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review.

    Togioka BM, Burwick RM, Kujovich JL

    Journal of anesthesia 2021; (35(2)):288-302 doi:10.1007/s00540-021-02911-1.

    PMID: 33682038

This page is for informational purposes only and does not constitute medical advice. A hematologist and obstetrician should help interpret your factor levels and plan care for bleeding, procedures, pregnancy, or delivery.